Menu
Deep Transcranial Magnetic Stimulation (Deep TMS) offers several advantages over traditional Transcranial Magnetic Stimulation (TMS), making it a preferred option for some individuals:
Targeting deeper brain regions
Enhanced efficacy
Reduced treatment time:
Improved tolerability
Expanded treatment options
Technology has improved at a rapid pace over recent decades – shouldn’t your TMS system as well?
Brainsway Deep TMS™ is the most advanced TMS technology available, with a number of key advantages over Traditional TMS systems. Through unparalleled innovation, clinical research, and use in hundreds of clinics and hospitals throughout the world, only Brainsway is advancing Deep TMS into new therapy areas in psychiatry, neurology, and addiction medicine.
Brainsway’s unique coil design enables deeper and broader stimulation than traditional, figure-8 TMS coils, resulting in greater activation of neurons, less likelihood of targeting errors, and high efficacy rates. Traditional TMS coils have changed minimally since first used in 1985. Clinical advantages of Deep TMS over traditional TMS have been validated through an independent head-to-head study of TMS technologies.
Brainsway is leading the development of novel treatments for a broad range of brain disorders.
Unlike traditional TMS systems that focus mainly on treating Major Depressive Disorder (MDD), Viking psychiatryDeep TMS is the only TMS device with peer-reviewed clinical data demonstrating efficacy for MDD, Anxious Depression, OCD, and Smoking Addiction.
Brainsway Deep TMS has been validated in 60+ randomized controlled trials (RCTs) with sham (placebo) involving over 3,000 patients and is currently being evaluated in 10+ ongoing RCTs. Research on Deep TMS has led to 300+ publications. No traditional TMS company has committed to this level of study of their technology.
In everyday use, nearly 600 Brainsway systems are in operation across North America, and approximately 100,000 patients have been treated in over 2.5 million treatment sessions.
Deep TMS technology, unique to BrainsWay, enables non-invasive activation of deeper and broader brain structures than traditional figure-8 coil TMS systems, allowing the H-Coil to potentially address a wider range of neuropsychiatric conditions.
With all forms of TMS, the intensity of stimulation naturally decays as it reaches deeper into the brain. The unique coil design allows for the strength of stimulation to be maintained at effective levels even in regions deeper within the brain that are affiliated with the indications we treat1.
For patients who are older, traditional TMS may not penetrate deep enough to generate a therapeutic effect, as in the case of late-life depression.
Deep TMS technology, unique to BrainsWay, enables non-invasive activation of deeper and broader brain structures than traditional figure-8 coil TMS systems, allowing the H-Coil to potentially address a wider range of neuropsychiatric conditions.
With all forms of TMS, the intensity of stimulation naturally decays as it reaches deeper into the brain. Our unique coil design allows for the strength of stimulation to be maintained at effective levels even in regions deeper within the brain that are affiliated with the indications we treat1.
For patients that are older, traditional TMS may not penetrate deep enough to generate a therapeutic effect, as in the case of late-life depression3.
Deep TMS technology, unique to BrainsWay, enables non-invasive activation of deeper and broader brain structures than traditional figure-8 coil TMS systems, allowing the H-Coil to potentially address a wider range of neuropsychiatric conditions.
With all forms of TMS, the intensity of stimulation naturally decays as it reaches deeper into the brain. Our unique coil design allows for the strength of stimulation to be maintained at effective levels even in regions deeper within the brain that are affiliated with the indications we treat1.
For patients that are older, traditional TMS may not penetrate deep enough to generate a therapeutic effect, as in the case of late-life depression3.
The only independent, head-to-head study of TMS technologies, published in the Journal of Psychiatric Research, determined that Deep TMS plus standard medication was significantly more effective at reducing depression levels among Major Depressive Disorder (MDD) patients compared with Traditional TMS* plus medication or medication alone5.
Deep TMS had no difference in safety or tolerability from Traditional TMS.
*The Magstim® Rapid² device was used in this study.(Magstim Company, Spring Gardens, UK)
BrainsWay’s touchscreen interface is designed to be user-friendly and guides the operator through the process of determining a patient’s motor threshold intensity and coil positioning. This innovative feature allows the setup process for each patient to be quicker than other traditional TMS systems.
With a traditional TMS system, the clinic is restricted to using a specific chair. The patient’s head is immobilized. Any movement, even a 1mm shift, could result in missing the target.
BrainsWay’s H-Coils are integrated into a cushioned, cooled helmet, allowing the patient to retain mobility during the treatment without compromising treatment accuracy. Clinics can select any chair they deem comfortable for the benefit of the client. The flexibility also allows for patients with mobility issues, such as those in wheelchairs.
